Security Snapshot

Progyny, Inc. - Common Stock (PGNY) Institutional Ownership

CUSIP: 74340E103

13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

313

Shares (Excl. Options)

80,287,830

Price

$25.68

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
PGNY on Nasdaq
Shares outstanding
81,916,070
Price per share
$16.98
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
80,287,830
Total reported value
$2,061,780,031
% of total 13F portfolios
0%
Share change
-2,443,574
Value change
-$49,660,729
Number of holders
313
Price from insider filings
$16.98
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • PGNY - Progyny, Inc. - Common Stock is tracked under CUSIP 74340E103.
  • 313 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 313 to 94 between Q4 2025 and Q1 2026.
  • Reported value moved from $2,061,780,031 to $140,518,312.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 313 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 74340E103?
CUSIP 74340E103 identifies PGNY - Progyny, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Progyny, Inc. - Common Stock (PGNY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 13% $255,409,242 11,153,242 BlackRock, Inc. 31 Mar 2025
FMR LLC 7.6% +42% $141,367,020 +$39,951,579 6,569,099 +39% FMR LLC 30 Sep 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 6.5% $90,967,141 5,357,311 Vanguard Portfolio Management 31 Mar 2026
THRIVENT FINANCIAL FOR LUTHERANS 6.3% $122,534,900 5,350,869 THRIVENT FINANCIAL FOR LUTHERANS 31 Mar 2025

As of 31 Dec 2025, 313 institutional investors reported holding 80,287,830 shares of Progyny, Inc. - Common Stock (PGNY). This represents 98% of the company’s total 81,916,070 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Progyny, Inc. - Common Stock (PGNY) together control 74% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 12,958,619 -13% 0.01% $332,777,337
VANGUARD GROUP INC 12% 9,633,382 -4.7% 0% $247,385,250
FMR LLC 8% 6,566,910 -0.03% 0.01% $168,638,240
STATE STREET CORP 3.6% 2,953,186 +1.5% 0% $75,837,816
AMERIPRISE FINANCIAL INC 2.8% 2,278,049 +21% 0.01% $58,500,299
WELLINGTON MANAGEMENT GROUP LLP 2.7% 2,243,268 +261% 0.01% $57,607,123
CITADEL ADVISORS LLC 2.6% 2,160,796 +134% 0.04% $55,489,241
GEODE CAPITAL MANAGEMENT, LLC 2.4% 1,972,219 +1.1% 0% $50,655,068
Thrivent Financial for Lutherans 2.3% 1,895,605 -12% 0.09% $48,679,000
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ 2.2% 1,834,104 +11% 0.25% $47,099,791
DIMENSIONAL FUND ADVISORS LP 2.1% 1,712,039 +12% 0.01% $43,966,358
ArrowMark Colorado Holdings LLC 1.8% 1,474,176 -24% 0.83% $37,856,840
FRED ALGER MANAGEMENT, LLC 1.7% 1,416,816 -17% 0.14% $36,383,835
MORGAN STANLEY 1.6% 1,286,631 +5.8% 0% $33,040,695
BAILLIE GIFFORD & CO 1.5% 1,262,691 +0.44% 0.03% $32,425,905
BARCLAYS PLC 1.4% 1,172,436 -26% 0.01% $30,108,156
GOLDMAN SACHS GROUP INC 1.4% 1,108,761 -28% 0% $28,472,982
Allianz Asset Management GmbH 1.1% 861,679 +4142% 0.03% $22,127,917
Nuveen, LLC 1% 840,093 -13% 0.01% $21,573,589
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1% 836,652 0.01% $21,485,223
RENAISSANCE TECHNOLOGIES LLC 1% 818,367 -18% 0.03% $21,015,665
NORTHERN TRUST CORP 0.99% 811,876 -4.9% 0% $20,848,976
LOOMIS SAYLES & CO L P 0.95% 775,580 0.02% $19,916,894
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.89% 732,431 -0.09% 0% $18,808,828
JPMORGAN CHASE & CO 0.85% 692,619 -22% 0% $17,786,455

Institutional Holders of Progyny, Inc. - Common Stock (PGNY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 8,276,063 $140,518,312 -$16,705,714 $16.98 94
2025 Q4 80,287,830 $2,061,780,031 -$49,660,729 $25.68 313
2025 Q3 82,627,341 $1,777,986,261 +$8,600,418 $21.52 297
2025 Q2 82,182,744 $1,808,928,546 +$111,821,013 $22.00 300
2025 Q1 77,183,020 $1,724,181,732 -$67,194,852 $22.34 285
2024 Q4 83,182,708 $1,434,904,618 -$6,291,222 $17.25 261
2024 Q3 82,854,480 $1,388,583,425 -$243,580,767 $16.76 280
2024 Q2 88,831,170 $2,541,381,282 +$37,012,636 $28.61 321
2024 Q1 86,132,927 $3,284,410,861 -$97,053,501 $38.15 320
2023 Q4 89,113,064 $3,313,335,480 +$24,400,952 $37.18 312
2023 Q3 93,647,005 $3,185,948,883 +$85,301,238 $34.02 322
2023 Q2 90,763,542 $3,569,724,669 -$3,939,876 $39.34 307
2023 Q1 91,300,299 $2,932,073,532 +$15,867,880 $32.12 274
2022 Q4 92,689,670 $2,887,335,680 +$95,419,970 $31.15 262
2022 Q3 82,041,636 $3,042,163,204 -$37,929,820 $37.06 272
2022 Q2 81,705,154 $2,374,320,096 +$7,055,928 $29.05 236
2022 Q1 80,693,892 $4,146,388,786 +$211,374,758 $51.40 243
2021 Q4 76,737,437 $3,864,895,222 +$64,193,382 $50.35 253
2021 Q3 82,419,604 $4,616,334,555 +$280,118,750 $56.00 259
2021 Q2 77,032,980 $4,545,430,258 +$354,459,447 $59.00 273
2021 Q1 72,252,934 $3,216,616,206 +$119,842,910 $44.51 204
2020 Q4 70,145,602 $2,973,667,456 +$336,268,366 $42.39 179
2020 Q3 50,501,119 $1,486,213,736 +$168,572,301 $29.43 142
2020 Q2 46,630,001 $1,203,141,737 +$368,466,559 $25.81 121
2020 Q1 32,385,474 $686,386,691 +$49,307,688 $21.19 80
2019 Q4 29,845,045 $817,169,849 +$816,841,856 $27.45 72
2019 Q3 3,376 $199,000 $58.95 1
2019 Q2 3,376 $199,000 $58.95 1
2019 Q1 3,376 $199,000 $58.95 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .